Home  >  TopNews
you can get e-magazine links on WhatsApp. Click here
+ Font Resize -

IPA wants Regulatory Affairs Science as academic discipline for higher education in pharmacy

Peethaambaran Kunnathoor, Chennai
Wednesday, June 24, 2015, 08:00 Hrs  [IST]

The Regulatory Affairs Division (RAD) of the Indian Pharmaceutical Association (IPA) wants Regulatory Affairs Science as an academic discipline and a research topic as part of higher education in pharmacy.

In respect of this field of study, RAD is conceiving ideas from experienced drug regulatory officers, expert leaders of industry and prominent academicians, said Dr Subhash Mandal, chairman of RAD of IPA.

He said PG and research programmes in Regulatory Affairs Sciences have developed in some western countries and several universities offer higher level academic programmes in the subject. In India, discussions are going on among experts to justify its status as an independent academic discipline in the pharmacy education. RAD will apprise the Union government and the office of the Drugs Controller General of India (DCGI) of the necessity of introducing Regulatory Affairs as an academic discipline.

He pointed out that in today’s world when crores of rupees worth drugs are consumed everyday by people in the country and the industry manufactures millions of rupees worth drugs for domestic and international sale, regulatory professionals of the central and state agencies need to learn and acquire specialized knowledge and practical skill about regulatory aspects of pharmaceuticals, neutraceuticals, cosmetics, biotechnology, medical devices, food, herbal drugs and other life-science industries. Pharmaceutical Regulatory Affairs professionals are responsible for developing, compiling and filing documentation required to support the licensing and approval of pharmaceutical products.

Dr Mandal said that with an aim to bring up this science into the pharmacy academic domain, last year RAD had organised seminars and workshops on the concept and importance of regulatory affairs in various pharmacy colleges, and discussions held among academic groups, research groups and industries. The residuary work will be carried out this year. He said once the subject becomes an academic discipline, it will provide the students with the knowledge and skills required to fulfill vital roles in assuring adherence with the complex regulations necessary for the development, delivery and marketing of safe and effective health-care products.

For an international level progress of the subject, RAD will contact regulatory authorities in foreign countries such as USFDA (USA), MHRA (UK), TGA (Australia), Health Canada (Canada), MCC (South Africa), ANVISA (Brazil), EMEA (European Union), SFDA (China), NAFDAC (Nigeria), MEDSAFE (New Zealand), MHLW (Japan), MCAZ (Zimbabwe), SWISSMEDIC (Switzerland), KFDA (Korea), MoH (Sri Lanka), etc.

Regulatory Science is the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of all regulated products. The course on the subject will have several disciplines like operational regulatory affairs, strategic regulatory affairs, clinical research regulatory affairs, international regulatory affairs, regulatory compliance, and general regulatory affairs, said Dr Subhash Mandal.

Follow on LinkedIn
Post Your commentsPOST YOUR COMMENT
* Name :     
* Email :    
  Website :  
Dziesevotuo Jun 27, 2015 4:37 PM
The complexicity of pharmaceutical field is increasing day by day as advancement is fast, therefore intrduction of regulatory affairs must be a welcome in our country pharma academia too,rather we are gatting late except some few private advance university has introduce this subject under clinical research. It is felt that this subject when introduce must cover even practice sector (pharmaceutico legal subject) practicing pharmacist,medical,nursing are subjecting to much risk in present health care,hence covering practising pharmacists under pharma regulatory affairs would be benefical for practising pharmacist.Till date any development undertaken emphasise only on industrial sector.
Bpharm.MSc clinical research regulatory affairs.
MSc. Bioinformatics
Dr C Gopalakrishna Murty Jun 26, 2015 10:16 AM
Dear Dr Mandal, I appreciate your idea of introducing Regulatory Affairs as a special subject in acedemics as well as a research subject for post graduate and doctorate degrees. As you have rightly stated , this assumes a lot of importance in the present circumstances in the pharma world. I whole heartedly support your views. Thanks
Copyright © 2024 Saffron Media Pvt. Ltd | twitter